Feed Preview

B-Cell Leukemia (Keystone)

B-Cell Leukemia  (Keystone) diagram by Mary Ann Thompson, Wikimedia
Mary Ann Thompson, Wikimedia

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Top 20 most recent papers
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation

Comparison of outcomes of myeloablative allogeneic stem cell transplantation for pediatric patients with bone marrow failure, myelodysplastic syndrome and acute myeloid leukemia with and without germline GATA2 mutations

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow TransplantationFebruary 24, 2020
Inga HofmannLeslie Lehmann
1
European Journal of Immunology

Hhex regulates murine lymphoid progenitor survival independently of Stat5 and Cdkn2a

European Journal of ImmunologyFebruary 25, 2020
Jacob T JacksonMatthew P McCormack
Blood

How I Manage CLL with Venetoclax-Based Treatments

BloodFebruary 21, 2020
William George Wierda, Francesco Paolo Tambaro
2
Leukemia

TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia

LeukemiaFebruary 23, 2020
Eva SzenesTanja Nicole Hartmann
1
Histopathology

Diagnosis of classic Hodgkin lymphoma on bone marrow biopsy

HistopathologyFebruary 25, 2020
Camille LaurentAyoma D Attygalle
Cancer Immunology, Immunotherapy : CII

Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer

Cancer Immunology, Immunotherapy : CIIFebruary 23, 2020
Mizuho OharaHiroya Kobayashi
Expert Opinion on Biological Therapy

The up-to-date role of biologics for the treatment of chronic lymphocytic leukemia

Expert Opinion on Biological TherapyFebruary 25, 2020
Iwona HusTadeusz Robak
Antiviral Research

Adoptive T-cell therapy for HBV-associated HCC and HBV infection

Antiviral ResearchFebruary 23, 2020
Anthony T Tan, Sophia Schreiber
International Immunopharmacology

PD-1 regulates CXCR5+ CD4 T cell-mediated proinflammatory functions in non-small cell lung cancer patients

International ImmunopharmacologyFebruary 23, 2020
Weiwei ShiShunchang Jiao
1

See more papers from this feed

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Anthracycline Sensitivity & Chromatin (Keystone)

Anthracyclines are used in the treatment of cancer and work by inhibiting topoisomerase II (TOP2). Recent evidence suggests that because DNA accessibility is crucial for TOP2 binding, chromatin regulatory genes should predict anthracycline response. Find the latest research on anthracycline sensitivity and chromatin regulators in this feed.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chemical Tools (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Using novel chemical tools allows us to learn more about these epigenetic changes and how they impact the neoplastic process. Follow this feed to learn more about cancer epigenetics and chemical tools.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

© 2020 Meta ULC. All rights reserved
/feed-previews/b-cell-leukemia-keystone/e5e66ccc-f234-4039-b472-004df1364d28